# Octapharma Plasma Inc – FDA Inspection, Jul 10, 2026

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/e00e4431-7140-48fe-841b-189d5fcd5fe4
Source feed: FDA_Inspections

> FDA inspection 1327022 of Octapharma Plasma Inc, July 10, 2026. 1 citation under 21 CFR part 606. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1327022
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2026-07-10
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: New Jersey District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1214337 - 2023-07-21

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/kish-bolden/e24957d4-927f-40c7-a7ca-860fedce2e3f)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/91eef912-b5fc-4a98-ac5f-b928e91c58b8

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248
